L.M. Kohn & Company’s Meridian Bioscience Inc VIVO Stock Holding History

L.M. Kohn & Company’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,500	Closed	-$382K	–	240
2022 Q4	$382K	Hold	11,500	–	–	0.18%	134
2022 Q3	$363K	Hold	11,500	–	–	0.18%	141
2022 Q2	$350K	Sell	11,500 -8,000	-41%	-$216K	0.16%	153
2022 Q1	$507K	Buy	+19,500	New	+$464K	0.2%	130

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

L.M. Kohn & Company's VIVO Position: Q1 2023 in Review

L.M. Kohn & Company sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 11,500 shares — an estimated $382K sold.

L.M. Kohn & Company first reported a position in VIVO in Q1 2022 and held it in 4 quarters. The position peaked at $507K in Q1 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

L.M. Kohn & Company reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
L.M. Kohn & Company sold 11,500 Meridian Bioscience Inc shares in Q1 2023, an estimated $382K.
L.M. Kohn & Company first reported a position in Meridian Bioscience Inc in Q1 2022 and held it in 4 quarters.
L.M. Kohn & Company's Meridian Bioscience Inc position peaked at $507K in Q1 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on L.M. Kohn & Company's 13F filing for Q1 2023, filed 8 May 2023.